GME FTX token prospectus located. Link in comments

page 1066

3.4. BASIC INFORMATION ON THE PUBLIC OFFER OF SECURITIES 3.4.1 On what terms and according to what schedule can I invest in this security? These securities are being and may be offered and sold only to persons who are permitted to acquire, hold and sell such securities under the laws applicable to them from time to time. The securities have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States or to, or for the account or benefit of, US persons who are citizens or residents of the United States for tax purposes. The Securities will be offered on the day following the publication of the Final Terms. Investors can redeem the Tokenized Stocks for cryptocurrencies or Swiss francs via the Issuer's website. The cryptocurrencies permitted for the purpose of payment will be announced on the Issuer's website in each case. The Issuer reserves the right to add certain cryptocurrencies to the list of eligible cryptocurrencies or to remove certain cryptocurrencies from the list of eligible cryptocurrencies at its sole discretion. 3.4.2 Who is the Offeror? The Offeror is Canco LLC with its registered office in Munich, registered in and incorporated under the laws of the Federal Republic of Germany. 3.4.3 Why is this prospectus being published? The Prospectus serves as the offering document for the issue of the Tokenized Stocks. The proceeds from the sale of the securities will be used for hedging transactions. The managing director of the Issuer is also the managing director of the parent company. At the same time, he is the majority shareholder of MKY Group, which prepared the financial statements. There is a risk that, due to conflicts of interest for or against the Issuer on the one hand or self-interest on the other, the aforementioned person may make decisions or take actions that may have a direct or indirect adverse effect on the economic success of the Issuer and thus ultimately also an indirect adverse effect on the net assets, financial position and results of operations of the Issuer. This may occur, for example, if remuneration or other benefits are granted in contracts or other legal relationships with the aforementioned persons which deviate not insignificantly from the remuneration or benefits customary in the market at the expense of the Issuer. In the opinion of the Issuer, however, this has not occurred in the contractual relationships with the aforementioned persons existing on the Prospectus Date

/r/Superstonk Thread Link - reddit.com